News tagged with acute coronary syndromes

Related topics: heart attack

No benefit to prolonging bivalirudin after PCI

Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of percutaneous coronary intervention (PCI) does not improve outcomes compared to stopping the treatment immediately after the ...

Sep 01, 2015
popularity10 comments 0

ELIXA trial shows CV safety of Lixisenatide

In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the ...

Aug 31, 2015
popularity9 comments 0

Subscribe to rss feed